ground glass nodules located in the pulmonary hilar region
Conditions
Interventions
lobectomy:lobectomy
Sponsors
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The age ranged from 18 to 75 years old, male or female; 2. GGO lesions in the hilar region were diagnosed by imaging examination (CT / PET-CT). During the follow-up of 6-12 months, the lesions increased by more than 2mm, the solid components increased, or there were obvious solid components, or the GGOs were judged to be highly malignant by imaging. 3. The size of GGO lesions was 8mm-3cm, and the number of nodules was = 3. 4. There was no lymph node metastasis, intrapulmonary metastasis or distant organ metastasis; 5. After multidisciplinary evaluation, the patients were feasible for lobectomy and CT guided microwave treatment; 6. No bleeding tendency, normal coagulation function or coagulation dysfunction can be corrected after treatment; 7. Patients and /or family members agreed to join the clinical trial and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. The general condition of the patient is very poor, ECOG physical fitness score > 2, unable to tolerate lobectomy and MWA treatment, or has relevant contraindications; 2. The lesions had received other treatments before; patients with regional lymph node metastasis or distant metastasis or with pleural fluid and ascites; 3. Patients with poor compliance; 4. Severe heart, lung, kidney, brain and other important organ diseases; 5. The researcher believes that it is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year recurrence-free survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative hospital stay;Total hospitalization expenses; | — |
Countries
China
Contacts
Public ContactJiachang Chi
Renji Hospital, School of Medicine, Shanghai Jiao-tong University
Outcome results
None listed